Thrombin activatable fibrinolysis inhibitor and its relationship to fibrinolysis and inflammation during the acute and convalescent phase of ischemic stroke
E Rooth, H Wallen, A Antovic, M Von Arbin… - Blood coagulation & …, 2007 - journals.lww.com
To investigate thrombin activatable fibrinolysis inhibitor (TAFI) in ischemic stroke and its
relationship to fibrinolysis and inflammation, we investigated 32 patients with ischemic
stroke during the acute phase and after 60 days. TAFI antigen levels, global markers of
hemostasis (coagulation and fibrinolysis) and inflammatory markers were measured in
plasma. TAFI antigen levels were significantly elevated at admission (128%; 109–151%)
and at day 1 (129%; 109–152%) compared with day 60 (108%; 91–127%; both P< 0.01) and …
relationship to fibrinolysis and inflammation, we investigated 32 patients with ischemic
stroke during the acute phase and after 60 days. TAFI antigen levels, global markers of
hemostasis (coagulation and fibrinolysis) and inflammatory markers were measured in
plasma. TAFI antigen levels were significantly elevated at admission (128%; 109–151%)
and at day 1 (129%; 109–152%) compared with day 60 (108%; 91–127%; both P< 0.01) and …